Personal CFO Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $951K | Sell |
|
|||||
|
2025
Q2 | $922K | Sell |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $1.32M | Buy |
|
|||||
|
2024
Q3 | $590K | Buy |
|
|||||
|
2024
Q2 | $555K | Buy |
|
|||||
|
2024
Q1 | $491K | Sell |
|
|||||
|
2023
Q4 | $462K | Sell |
|
|||||
|
2023
Q3 | $486K | Sell |
|
|||||
|
2023
Q2 | $425K | Sell |
|
|||||
|
2023
Q1 | $500K | Buy |
|
|||||
|
2022
Q4 | $418K | Sell |
|
|||||
|
2022
Q3 | $500K | Sell |
|
|||||
|
2022
Q2 | $447K | Buy |
|
|||||
|
2022
Q1 | $526K | Sell |
|
|||||
|
2021
Q4 | $698K | Buy |
|
|||||
|
2021
Q3 | $392K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $822K | Buy |
|
|||||
|
2020
Q3 | $1K | Sell |
|
|||||
|
2020
Q2 | $1.07M | Buy |
|
|||||
|
2020
Q1 | $833K | Buy |
|
|||||
|
2019
Q4 | $593K | Sell |
|
|||||
|
2019
Q3 | $480K | Buy |
|